Cytek Biosciences, Inc. (CTKB)
NASDAQ · Healthcare
Cytek Biosciences, Inc. Price to FCF Ratio 2021–2026
Price to free cash flow (P/FCF) ratio for Cytek Biosciences, Inc. (CTKB): market cap divided by trailing twelve-month free cash flow. As of September 30, 2025 it is 20.25.
From: 06/30/2021To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF
Cytek Biosciences, Inc. Price to FCF Ratio — FAQ
Cytek Biosciences, Inc. (CTKB) price to fcf ratio over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTKB's price to fcf ratio history?
The chart and table above show Cytek Biosciences, Inc.'s price to fcf ratio by year and by quarter, including the growth rate.